NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E- EPS (ttm)-0.15 Insider Own49.43% Shs Outstand126.85M Perf Week17.73%
Market Cap539.13M Forward P/E21.70 EPS next Y0.20 Insider Trans0.36% Shs Float64.15M Perf Month51.25%
Enterprise Value596.40M PEG- EPS next Q-0.05 Inst Own51.46% Short Float16.85% Perf Quarter-2.30%
Income-18.63M P/S1.18 EPS this Y754.67% Inst Trans4.22% Short Ratio7.54 Perf Half Y34.49%
Sales458.76M P/B2.22 EPS next Y199.16% ROA-3.43% Short Interest10.81M Perf YTD32.81%
Book/sh1.91 P/C4.88 EPS next 5Y- ROE-4.92% 52W High6.71 -36.66% Perf Year57.41%
Cash/sh0.87 P/FCF- EPS past 3/5Y-79.03% - ROIC-4.64% 52W Low2.28 86.40% Perf 3Y-10.34%
Dividend Est.- EV/EBITDA19.31 Sales past 3/5Y1.04% 13.06% Gross Margin71.54% Volatility6.44% 6.58% Perf 5Y10.68%
Dividend TTM- EV/Sales1.30 EPS Y/Y TTM-432.51% Oper. Margin1.18% ATR (14)0.24 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.67 Sales Y/Y TTM5.35% Profit Margin-4.06% RSI (14)71.67 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.12 EPS Q/Q-975.47% SMA2024.02% Beta1.75 Target Price6.33
Payout0.00% Debt/Eq0.12 Sales Q/Q-21.17% SMA5017.23% Rel Volume0.34 Prev Close4.05
Employees869 LT Debt/Eq0.09 EarningsMay 08 AMC SMA20016.18% Avg Volume1.43M Price4.25
IPOJan 05, 2017 Option/ShortYes / Yes EPS/Sales Surpr.-353.33% -4.49% Trades Volume493,958 Change4.94%
Date Action Analyst Rating Change Price Target Change
Jun-28-24Initiated Lake Street Buy $5
Feb-07-24Initiated Cantor Fitzgerald Overweight $5
Jun-15-23Initiated Morgan Stanley Equal-Weight $5
May-24-23Upgrade BTIG Research Neutral → Buy $10
Nov-10-22Downgrade BTIG Research Buy → Neutral
Aug-10-22Downgrade Oppenheimer Outperform → Perform
Jan-10-20Initiated SVB Leerink Outperform $9
Aug-26-19Resumed Credit Suisse Outperform $9 → $10
May-02-19Initiated Credit Suisse Outperform $9
Apr-17-19Initiated Oppenheimer Outperform $11
May-09-25 03:51AM
May-08-25 06:05PM
04:57PM
04:05PM
May-07-25 10:41AM
04:05PM Loading…
Apr-11-25 04:05PM
Apr-07-25 04:05PM
Feb-28-25 11:14AM
02:42AM
12:45AM
Feb-27-25 05:32PM
04:05PM
Feb-26-25 08:09AM
Jan-27-25 07:30AM
Nov-22-24 04:05PM
09:25AM Loading…
Nov-15-24 09:25AM
Nov-13-24 02:23AM
Nov-12-24 09:45PM
05:40PM
04:37PM
04:05PM
04:01PM
Nov-11-24 05:05PM
Oct-16-24 07:30AM
Oct-01-24 04:05PM
Sep-04-24 04:05PM
Aug-09-24 12:30AM
Aug-08-24 09:57PM
06:35PM
05:24PM
04:05PM Loading…
04:05PM
04:04PM
Jul-20-24 01:44AM
Jul-15-24 04:05PM
Jun-06-24 04:05PM
May-10-24 03:09PM
12:07PM
11:49AM
May-09-24 08:45PM
05:41PM
04:05PM
May-02-24 07:00AM
Apr-16-24 07:30AM
Apr-03-24 07:30AM
Mar-02-24 08:39AM
Mar-01-24 06:29PM
Feb-29-24 05:45PM
04:50PM
04:38PM
04:05PM
Feb-12-24 07:30AM
Feb-08-24 04:05PM
Jan-15-24 12:00PM
Dec-28-23 12:00PM
Dec-19-23 05:08AM
Nov-11-23 09:30AM
Nov-10-23 06:47AM
Nov-09-23 07:45PM
05:41PM
04:05PM
Oct-30-23 09:32AM
Oct-05-23 07:30AM
Sep-28-23 11:44AM
09:15AM
Sep-06-23 04:05PM
Aug-10-23 11:54AM
06:17AM
Aug-09-23 08:30PM
04:43PM
04:05PM
Jul-31-23 03:33PM
Jul-10-23 07:30AM
Jul-03-23 06:00AM
May-30-23 06:21AM
May-24-23 03:02PM
May-13-23 11:32AM
May-11-23 02:33PM
03:30AM
May-10-23 04:28PM
04:05PM
Apr-29-23 09:58AM
Apr-27-23 07:30AM
Apr-10-23 07:30AM
Apr-02-23 09:30AM
Mar-27-23 08:00AM
Mar-07-23 07:50AM
Mar-06-23 06:29PM
Mar-04-23 07:47AM
Mar-03-23 06:56PM
Mar-02-23 12:10PM
Mar-01-23 09:00PM
04:02PM
04:01PM
Feb-09-23 07:30AM
Dec-05-22 07:30AM
Nov-09-22 10:00PM
04:05PM
07:18AM
Sep-26-22 09:12AM
07:57AM
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Freedman LoriChief Admin. and Legal OfficerJun 05 '25Buy2.91142,379413,625837,437Jun 06 05:44 PM
Freedman LoriChief Admin. and Legal OfficerJun 04 '25Buy2.82100,863284,716695,058Jun 06 05:44 PM
Freedman LoriChief Admin. and Legal OfficerJun 06 '25Buy2.999,02226,949846,459Jun 06 05:44 PM
Driscoll Michael JosephDirectorMar 04 '25Proposed Sale5.0825,000127,000Mar 17 05:14 PM
Driscoll Michael JosephDirectorMar 04 '25Sale5.1025,000127,535166,879Mar 06 09:08 PM
Gillheeney Gary S.President and CEODec 13 '24Sale3.3655,615186,8663,044,779Dec 16 08:03 PM
Gillheeney Gary S.President and CEODec 16 '24Sale3.495,58519,4923,039,194Dec 16 08:03 PM
Gillheeney Gary S.President and CEODec 11 '24Sale3.64157,448573,1113,143,753Dec 12 08:08 PM
Gillheeney Gary S.President and CEODec 10 '24Sale3.6458,525213,0313,301,201Dec 12 08:08 PM
Gillheeney Gary S.President and CEODec 12 '24Sale3.5543,359153,9243,100,394Dec 12 08:08 PM
Gillheeney Gary S.President and CEODec 05 '24Option Exercise0.991,067,2451,056,5733,419,194Dec 09 08:05 PM
Gillheeney Gary S.President and CEODec 09 '24Sale3.5241,052144,5033,359,726Dec 09 08:05 PM
Gillheeney Gary S.President and CEODec 06 '24Sale3.6518,41667,2183,400,778Dec 09 08:05 PM
Gillheeney Gary S.OfficerDec 06 '24Proposed Sale3.59380,0001,364,200Dec 06 04:01 PM